跳至主要内容
临床试验/RBR-5n4htp
RBR-5n4htp招募中1 期

Disulfiram repurposing in the combined chemotherapy of Chagas disease – Phase I/II Clinical Trial

Fundação Oswaldo Cruz0 个研究点开始时间: 2020年2月17日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 70Y(—)

入选标准

  • Adults; aged from 18 to 70 years; both sexes; diagnosis of chronic Chagas disease in the indeterminate form or cardiac form at stage A; two distinct serological tests (enzyme-linked immunosorbent assay and indirect immunofluorescence or chemiluminescence) positive for Chagas disease

排除标准

  • Previous benznidazol (BZ) or dissulfiram (DF) treatment, contraindications or hypersensitivity; alcoholism; smoking; renal or hepatic impairment; gastrointestinal disorders; pulmonary, epileptic, haematological disorders; pregnancy or lactation; heart disease associated with moderate or severe orovalvar disease, ischemic, congenital or hypertensive heart disease; systemic diseases such as autoimmune disorders, cancer, other infectious diseases such as acquired immunodeficiency syndrome; use of 3 or more regular medications within 2 weeks before starting study treatment except for contraceptive (for women), omeprazol and sinvastatin; use of any eventual medication within 7 days before starting study treatment; use of any antifungal 60 days before starting study treatment; previous intervention studies one year before; severe cognitive impairments

研究者

相似试验